The Multiple Myeloma Research Foundation (MMRF) is presenting today new data from the MMRF CoMMpass StudySM – the most comprehensive long-term genomic study ever conducted in myeloma and one that may significantly advance the understanding of multiple myeloma. The data provide significant insights into the genetics of multiple myeloma and the potential association to patient outcomes, as well as informing the development of more precision treatments for the disease.
Additional collaborating research partners include Translation Genomic Research Institute, Van Andel Research Institute, and GNS Healthcare.
Read the full press release here